Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$2.62M Sell
16,381
-154
-0.9% -$24.3K 0.38% 80
2014
Q4
$2.63M Buy
16,535
+1,024
+7% +$160K 0.41% 76
2014
Q3
$2.18M Buy
15,511
+2,025
+15% +$264K 0.35% 90
2014
Q2
$1.6M Buy
13,486
+2,363
+21% +$274K 0.27% 123
2014
Q1
$1.37M Buy
11,123
+295
+3% +$35.8K 0.27% 131
2013
Q4
$1.24M Buy
10,828
+758
+8% +$86.2K 0.41% 68
2013
Q3
$1.13M Buy
10,070
+839
+9% +$91K 0.44% 58
2013
Q2
$911K Buy
+9,231
New +$958K 0.32% 84

Other funds holding AMGN

Sterne Agee Group's AMGN Position: Q1 2015 in Review

Sterne Agee Group reduced its Amgen (AMGN) stake by 0.93% in Q1 2015, selling an estimated $24.3K and leaving 16,381 shares worth $2.62M. The position accounts for 0.38% of the portfolio, ranked #80.

Sterne Agee Group first reported a position in AMGN in Q2 2013 and has held it in 8 quarters since. The position peaked at $2.63M in Q4 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

  • Sterne Agee Group held 16,381 shares of Amgen worth $2.62M as of Q1 2015.
  • Sterne Agee Group sold 154 Amgen shares in Q1 2015, an estimated $24.3K.
  • Amgen made up 0.38% of Sterne Agee Group's portfolio in Q1 2015, its #80 holding.
  • Sterne Agee Group first reported a position in Amgen in Q2 2013 and has held it in 8 quarters since.
  • Sterne Agee Group's Amgen position peaked at $2.63M in Q4 2014.
  • 1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.